CLINICAL TRIALS PROFILE FOR SPINOSAD
✉ Email this page to a colleague
All Clinical Trials for Spinosad
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00311779 ↗ | A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis | Completed | ParaPRO LLC | Phase 2 | 2006-03-01 | The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice). |
| NCT00410709 ↗ | A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age | Completed | ParaPRO LLC | Phase 1 | 2006-12-01 | This is an open label, single center, single dose PK study of NatrOVA Creme Rinse (1%), an investigational treatment for head lice and nits, in normal, healthy infants. |
| NCT00545168 ↗ | Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice | Completed | ParaPRO LLC | Phase 3 | 2007-09-01 | A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (Head lice). |
| NCT00545753 ↗ | Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice | Completed | ParaPRO LLC | Phase 3 | 2007-09-01 | A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (human head lice). |
| NCT00858481 ↗ | A Pilot Dose Ranging Study of Spinosad Creme Rinse | Completed | ParaPRO LLC | Phase 2 | 2005-09-01 | A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control. |
| NCT01660321 ↗ | Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation | Completed | ParaPRO LLC | Phase 4 | 2011-09-01 | A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation. |
| NCT02485704 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | Accelovance | Phase 3 | 2017-05-10 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Spinosad
Condition Name
Clinical Trial Locations for Spinosad
Trials by Country
Clinical Trial Progress for Spinosad
Clinical Trial Phase
Clinical Trial Sponsors for Spinosad
Sponsor Name
